is semaglutide hard on your kidneys Novo unveils full results from its GLP-1 trial in CKD Renal effects of GLP-1 receptor

This article and its contents are provided for educational and informational purposes only and do not constitute medical advice or professional services specific to you or your medical condition.

This leads to lower blood glucose levels

Favorable results on weight have been reported for higher doses of oral semaglutide (25 and 50 mg daily), which are not yet in clinical use (19)

rather, it appears to modulate several biological pathways to promote healing

Incretin-based drugs are now being investigated and in some cases approved for a wide range of conditions, including cardiovascular disease, chronic kidney disease, sleep apnea, fatty liver disease (MASLD), neurodegenerative disorders, and even substance-use disorders

If you have already read "GLP-1 Not Working